Talking About Glaucoma (mp3)

Robert M Schertzer, MD, MEd, FRCSC

A podcast of indeterminant length and frequency that I launched in 2009. In each episode, I talk with a colleague about a hot topic in glaucoma. Help prevent progressive loss of vision by staying informed. Please provide written feedback on the Feedback page or leave voice mail using the microphone icon. Subscribe and rate on your podcast service of choice and Buy Me A Coffee to help support the show - it's a solo project and labour of love.

  1. 2023-03-24

    Ep 37 Talking About Glaucoma - 23Mar2023 KAMAT Shivani Plateau Iris (mp3)

    Intro: In this episode, I discuss Plateau Iris with Dr Shivani Kamat, Assistant Professor of Ophthalmology and Glaucoma Fellowship Program director at UT Southwestern. She also founded and co-chairs Women in Glaucoma. Today's discussion includes the difference between plateau iris configuration and syndrome, how to distinguish it from other glaucomas and treatment options. Outro: Talking About Glaucoma is a podcast of indeterminate frequency and duration...recently averaging 4 episodes per year. I'm still hoping to get this out monthly in the future. It’s free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, Podcast Addict, and many other podcast services. Please rate the podcast on your podcast player of choice, subscribe to it, and tell your friends about it so that it can reach more listeners and encourage me to continue to produce new episodes. Follow me at WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at podcast@iguy.org with your show ideas, if you would like to be on a future episode or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma. About Shivani Kamat (taken from the UT Southwestern Medical Centre website): Shivani Kamat, M.D., is an Assistant Professor in the Department of Ophthalmology and Director of the Glaucoma Fellowship at UT Southwestern Medical Center. She specializes in complex glaucoma, anterior segment disease, minimally invasive glaucoma surgery, and cataract surgery and has extensive experience in medical, laser, and surgical treatment of glaucoma, including combined cataract and glaucoma procedures as well as the latest glaucoma surgical devices and intraocular lens implant technology. Dr. Kamat earned her medical degree at the University of Florida in Gainesville. She completed an internship in internal medicine at the UF Health Shands Hospital, a residency in ophthalmology at Loyola University, and a fellowship in glaucoma at Massachusetts Eye and Ear, a primary teaching hospital of Harvard Medical School. Certified by the American Board of Ophthalmology, she joined the UT Southwestern faculty in 2022. Previously, she was an Assistant Professor at the University of Michigan Kellogg Eye Center in Ann Arbor, where she served as the Glaucoma Fellowship Director and the Medical Director of the center’s community clinic in Brighton, Michigan. Dr. Kamat founded and co-chairs Women in Glaucoma. She serves on multiple committees of the American Glaucoma Society and as an examiner for the American Board of Ophthalmology. She is also a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, and the Dallas Academy of Ophthalmology. Dr. Kamat is actively involved in clinical research; her interests include the epidemiology of glaucoma, minimally invasive glaucoma surgery, anterior segment disease, and plateau iris syndrome. She has lectured widely and published numerous research articles on these and related topics in publications such as Nature, Ophthalmology, JAMA Ophthalmology, Journal of Glaucoma, and EyeNet Magazine. In addition, she has served as a reviewer for the Journal of Glaucoma, contributed to a book on gonioscopy-assisted transluminal trabeculotomy, and been interviewed for stories in national magazines and digital platforms. Selected references: Shivani S Kamat, Helen L Kornmann, Kugler Publications. GATT in Secondary Glaucoma in GATT: Gonioscopy Assisted Transluminal Trabeculotomy- A Guide to Circumnavigating Schlemm's Canal from Around the World SS Kamat, MS Gregory, LR Pasquale - Seminars in ophthalmology, 2016 - Taylor & Francis. The role of the immune system in glaucoma: bridging the divide between immune mechanisms in experimental glaucoma and the human disease JR Ehrlich, AR Elam, D John, SS Kamat… - JAMA …, 2020 - jamanetwork.com Application of the sight outcomes research collaborative ophthalmology data repository for triaging patients with glaucoma and clinic appointments during pandemics SJ Garnai, LA Huryn, K Johnson, SS Kamat… - Scientific reports, 2020 - nature.com Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort M Rahman, C Andrews, JR Ehrlich, S Kamat… - JAMA …, 2019 - jamanetwork.com Evaluation of an algorithm for identifying ocular conditions in electronic health record data  WS Lieb, G Fabry, KN Allen, SS Kamat… - … & Visual Science, 2017 - arvojournals.org The ability of nitric oxide to lower intraocular pressure is dependent on guanylyl cyclase JA Musser, LM Niziol, MM Heisler, SS Kamat… - Journal of …, 2019 - ncbi.nlm.nih.gov Integrating patient education into the glaucoma clinical encounter: a lean analysis MM Shah, AR Elam, SS Kamat… - Clinical …, 2020 - Taylor & Francis The appropriateness of digital diabetic retinopathy screening images for a computer-aided glaucoma screening system Production information: This episode was recorded back on April 22, 2022 over Zoom. Mixing was finally completed March 20, 2023 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone through an SSL 2 USB Audio. The opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care. Robert M Schertzer, MD, MEd, FRCSCpodcast@iguy.org Twitter - https://twitter.com/robschertzeror http://iguy.tv/twitter Blog - http://wholelottarob.comor http://iguy.tv/blog Facebook - https://facebook.com/talkingaboutglaucoma Office website - https://westcoastglaucoma.comor http://iguy.tv/office YouTube channel - https://youtube.com/robschertzer Instagram - https://instagram.com/westcoastglaucoma Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr © 2023 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC iTunes Subtitle: A discussion with Shivani Kamat about Plateau Iris. The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options. iTunes Summary: In this episode, I talk with Dr Shivani Kamat, Associate Professor of Ophthalmology and Glaucoma Fellowship Program director at UT Southwestern, about Plateau Iris. The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options. SEO Title Discussion with Shivani Kamat about Plateau Iris SEO Description The discussion includes the difference between plateau iris configuration and syndrome, how to distinguish plateau iris from other glaucoma and its implication for treatment options. iTunes TAG 37

  2. 2022-06-07

    Ep 36 Talking About Glaucoma 6Jun2022 SIEGFRIED Carla The Perfect Trabeculectomy (mp3)

    Intro:In this episode, I talk with Carla Siegfried, Jacquelyn E. and Allan E. Kolker, MD Distinguished Professor of Ophthalmology and Vice-Chair of Diversity, Equity, and Professionalism at Washington University School of Medicine, about the gold standard glaucoma surgical procedure: the trabeculectomy. We exchange detailed tips for success for each step of the surgery and post-operative care. It is clear from our discussion that we must continue to train others so that the trabeculectomy does not become a lost art. This is a procedure requiring no special devices and remains the gold standard for achieving low pressures despite its higher complication rate compared to other procedures.There are some audio issues with the recording of this episode that I've cleaned up as best I can. I'm Rob Schertzer, a Vancouver, Canada-based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.Outro:Talking About Glaucoma is a podcast of indeterminate frequency and duration...recently averaging 4 episodes per year. I'm still hoping to get this out monthly in the future. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, Podcast Addict, and many other podcast services. Please rate the podcast on your podcast player of choice, subscribe to it, and tell your friends about it, so that it can reach more listeners and encourage me to continue to produce new episodes. Follow me at WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at podcast@iguy.org with your show ideas, if you would like to be on a future episode or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma.--------About Carla Siegfried:Carla J. Siegfried, MDJacquelyn E. and Allan E. Kolker, MD Distinguished Professor of OphthalmologyVice Chair of Diversity, Equity, and ProfessionalismJohn F. Hardesty, MD Department of Ophthalmology and Visual Sciences Washington University School of Medicine660 South Euclid Ave. MSC-8096-05-721St. Louis, MO 63110314-362-3937siegfried@wustl.eduSelected references from past 5 years:1: Ban N, Siegfried CJ, Apte RS. Monitoring Neurodegeneration in Glaucoma:Therapeutic Implications. Trends Mol Med. 2018 Jan;24(1):7-17. doi:10.1016/j.molmed.2017.11.004. Epub 2017 Dec 7. PMID: 29233479; PMCID:PMC5748344.2: Siegfried CJ. Setting the Gold(en) Standard for Ethical Care:#PatientCommunication. Ophthalmology. 2019 Mar;126(3):335-337. doi:10.1016/j.ophtha.2018.09.011. Epub 2018 Sep 19. PMID: 30240792.3: Van Gelder RN, Siegfried CJ. ROI, COI, and the Ethical Obligations ofJournals. Ophthalmology. 2022 Jun;129(6):602-604. doi:10.1016/j.ophtha.2022.04.007. PMID: 35598900.4: De Maria A, Zientek KD, David LL, Wilmarth PA, Bhorade AM, Harocopos GJ,Huang AJW, Hong AR, Siegfried CJ, Tsai LM, Sheybani A, Bassnett S. CompositionalAnalysis of Extracellular Aggregates in the Eyes of Patients With ExfoliationSyndrome and Exfoliation Glaucoma. Invest Ophthalmol Vis Sci. 2021 Dec1;62(15):27. doi: 10.1167/iovs.62.15.27. PMID: 34964803; PMCID: PMC8740535.5: Pelton RW, Siegfried CJ. Re: Bartley: Verifying surgical competence: ourfiduciary responsibility (Ophthalmology. 2020;127:997-999). Ophthalmology. 2020Dec;127(12):e111-e112. doi: 10.1016/j.ophtha.2020.06.022. Epub 2020 Jul 29.PMID: 32739188.6: Siegfried CJ, Shui YB. Intraocular Oxygen and Antioxidant Status: NewInsights on the Effect of Vitrectomy and Glaucoma Pathogenesis. Am J Ophthalmol.2019 Jul;203:12-25. doi: 10.1016/j.ajo.2019.02.008. Epub 2019 Feb 15. PMID:30772349; PMCID: PMC6612589.7: Siegfried CJ, Shui YB, Tian B, Nork TM, Heatley GA, Kaufman PL. Effects ofVitrectomy and Lensectomy on Older Rhesus Macaques: Oxygen Distribution,Antioxidant Status, and Aqueous Humor Dynamics. Invest Ophthalmol Vis Sci. 2017Aug 1;58(10):4003-4014. doi: 10.1167/iovs.17-21890. PMID: 28800647; PMCID:PMC5555251.—————————————————————————Production information:This episode was recorded February 29, 2020 during the Annual Meeting of the American Glaucoma Society in Washington, DC, unfortunately using a BOYA Dual Lapel USB-C Microphone BY-M3D - which I do not recommend. Mixing was finally completed to salvage the recording on May 9, 2022 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone through an SSL 2 USB Audio Interface onJune 6, 2022.The opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.Robert M Schertzer, MD, MEd, FRCSCpodcast@iguy.orgTwitter - https://twitter.com/robschertzeror http://iguy.tv/twitterBlog - http://wholelottarob.comor http://iguy.tv/blogFacebook - https://facebook.com/talkingaboutglaucomaOffice website - https://westcoastglaucoma.comor http://iguy.tv/officeYouTube channel - https://youtube.com/robschertzerInstagram - https://instagram.com/westcoastglaucomaTheme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr© 2022 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC

  3. 2022-02-22

    Ep 35 Talking About Glaucoma 21Feb2022 Steve Gedde Glaucoma Surgical Trials (mp3)

    TAG #35 GEDDE Steve - Glaucoma surgical trials: lessons learnedIntro:There have been many trials proving surgical intervention does indeed reduce the risk of progressive glaucoma damage for our patients. These include Treatment vs No Treatment studies as well as studies that compare different types of treatment. In this episode, I talk with Steve Gedde, from the University of Miami's Bascom Palmer Eye Institute, about lessons learned from these clinical trials.We begin by discussing the importance of Randomized Clinical Trials as the highest evidence-based medicine to compare treatments.Studies that we discuss include: the Fluorouracil Filtering Study Group; Tube vs Trab (TVT); Primary Tube vs Trab (PTVT); Ahmed Baervedlt Comparison (ABC); Ahmed vs Baerveldt. Some of the concepts and lessons learned include: reducing IOP prior to surgery to lessen the risk of choroidal hemorrhage from a sudden IOP drop; trabeculectomy offering titratable control that MIGS procedures do not; that it's harder to get a 20% reduction in IOP to count as a success if the IOP is lower than 25 pre-op; that Ahmed Valves have a better safety record but Baerveldt better pressure-lowering; and that antimetabolites have been shown to NOT be effective for tube-shunt surgery.There's quite a bit of information packed into this episode so I suggest checking the program notes for links to some relevant articles and presentations related to this topic.I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.Outro:Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts, subscribe to it, and tell your friends about it, so that it can reach more listeners and encourage me to continue to produce new episodes. Follow WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at podcast@iguy.org with your show ideas or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma. See you next time on Talking About Glaucoma.--------Steve Gedde is Professor of Ophthalmology, the John G. Clarkson Chair in Ophthalmology, Vice-Chair of Education and Residency Program Director at Bascom Palmer. --------We spoke in February 2020, one of three interviews I recorded at the last in-person American Glaucoma Society annual meeting prior to Covid. My apologies that all of these recordings were made using BOYA Dual Lapel USB-C BY-M3D mics plugged into an Android phone instead of my usual professional set-up. I've done my best to make the audio quality acceptable but the sound quality is not up to my usual high standards. Fortunately there is just one more episode with this low quality...so be sure to subscribe so you can get the good stuff when available.--------I'm Rob Schertzer, a Vancouver-based Glaucoma specialist, EMR guru and tech geek and we're...talking about glaucoma.About Steve Gedde:https://doctors.umiamihealth.org/provider/Steven+J+Gedde/524953Professor of OphthalmologyJohn G. Clarkson Chair in OphthalmologyVice Chair of Education and Residency Program DirectorSelected references:This link may have restricted access to American Glaucoma Society members. It is a lecture that Dr. Gedde delivered at the March 2020 AGS Annual Meeting in Washington DC entitled: Lessons Learned from Glaucoma Surgical Trialshttps://www.aao.org/annual-meeting-video/lessons-learned-from-glaucoma-surgical-trialsHere is a reasonably comprehensive list of glaucoma clinical trials, broken down as Treatment vs No Treatment and Treatment vs Treatmenthttps://eyewiki.aao.org/Clinical_Trials_in_Glaucoma—————————————————————————Production information:This episode was recorded February 29, 2020 during the Annual Meeting of the American Glaucoma Society in Washington, DC, unfortunately using a BOYA Dual Lapel USB-C Microphone BY-M3D - which I do not recommend. Mixing and sound levelling were finally completed to salvage the recording on February 21, 2022 using Hindenberg Journalist Pro software iZotope processing plug-ins on a Gigabyte AERO 17 computer. The narration was overdubbed using a Heil PR40 microphone. Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.Robert M Schertzer, MD, MEd, FRCSCpodcast@iguy.orgTwitter - https://twitter.com/robschertzeror http://iguy.tv/twitterBlog - http://wholelottarob.comor http://iguy.tv/blogFacebook - https://facebook.com/talkingaboutglaucomaOffice website - https://westcoastglaucoma.comor http://iguy.tv/officeYouTube channel - https://youtube.com/robschertzerInstagram - https://instagram.com/westcoastglaucomaTheme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr© 2022 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC—————————————————————————iTunes Subtitle:A talk with Steve Gedde on lessons learned from glaucoma surgery randomized controlled trials.iTunes Summary:In this episode, I talk with Steve Gedde, from the University of Miami's Bascom Palmer Eye Institute, about lessons learned from these clinical trials.We begin by discussing the importance of Randomized Clinical Trials as the highest evidence-based medicine to compare treatments. Studies that we discuss include: the Fluorouracil Filtering Study Group; Tube vs Trab (TVT); Primary Tube vs Trab (PTVT); Ahmed Baervedlt Comparison (ABC); Ahmed vs Baerveldt. Some of the concepts and lessons learned include: reducing IOP prior to surgery to lessen the risk of choroidal hemorrhage from a sudden IOP drop; trabeculectomy offering titratable control that MIGS procedures do not; that it's harder to get a 20% reduction in IOP to count as a success if the IOP is lower than 25 pre-op; that Ahmed Valves have a better safety record but Baerveldt better pressure-lowering; and that antimetabolites have been shown to not be effective for tube-shunt surgery.

About

A podcast of indeterminant length and frequency that I launched in 2009. In each episode, I talk with a colleague about a hot topic in glaucoma. Help prevent progressive loss of vision by staying informed. Please provide written feedback on the Feedback page or leave voice mail using the microphone icon. Subscribe and rate on your podcast service of choice and Buy Me A Coffee to help support the show - it's a solo project and labour of love.